Patents by Inventor Susanne Peters

Susanne Peters has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Microstructured absorbable implant
    Patent number: 9504554
    Abstract: The production of microstructured surfaces in magnesium alloys, containing zinc as the major alloying element, in particular in absorbable implants such as stents, wherein microstructures in sizes of up to 5 ?m (micrometers) are generated on a magnesium alloy base body of the absorbable implant, for example of the absorbable stent, by way of optionally combined, pickling and electrochemical micropolishing processes, and allow better adhesion of a polymer coating (including higher break resistance) and higher corrosion resistance. The microstructured surface is produced out of the bulk material and exhibits no delamination from the base material during the mechanical deformation of the implant.
    Type: Grant
    Filed: January 2, 2014
    Date of Patent: November 29, 2016
    Assignee: BIOTRONIK AG
    Inventors: Ullrich Bayer, Monika Badendieck, Susanne Peters, Thomas Drobek, Okechukwu Anopuo
  • Microstructured Absorbable Implant
    Publication number: 20140200652
    Abstract: The production of microstructured surfaces in magnesium alloys, containing zinc as the major alloying element, in particular in absorbable implants such as stents, wherein microstructures in sizes of up to 5 ?m (micrometers) are generated on a magnesium alloy base body of the absorbable implant, for example of the absorbable stent, by way of optionally combined, pickling and electrochemical micropolishing processes, and allow better adhesion of a polymer coating (including higher break resistance) and higher corrosion resistance. The microstructured surface is produced out of the bulk material and exhibits no delamination from the base material during the mechanical deformation of the implant.
    Type: Application
    Filed: January 2, 2014
    Publication date: July 17, 2014
    Applicant: BIOTRONIK AG
    Inventors: Ullrich Bayer, Monika Badendieck, Susanne Peters, Thomas Drobek, Okechukwu Anopuo
  • 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals
    Patent number: 6127426
    Abstract: Therapeutic compositions comprising 1,8-dihyroxy-9(10H) anthracenones substituted at position 10 thereof with phenylalkylidene or arylacyl blacking moieties, said compounds having substantial therapeutic activity and minimal inflammatory effect.
    Type: Grant
    Filed: November 19, 1998
    Date of Patent: October 3, 2000
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Klaus Muller, Wolfgang Wiegrebe, Dieter Gurster, Susanne Peters, nee Piwek
  • 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals
    Patent number: 5844004
    Abstract: Therapeutic compositions comprising 1,8-dihyroxy-9(10H) anthracenones substituted at position 10 thereof with phenylalkylidene or arylacyl blocking moieties, said compounds having substantial therapeutic activity and minimal inflammatory effect.
    Type: Grant
    Filed: March 27, 1997
    Date of Patent: December 1, 1998
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Klaus Muller, Wolfgang Wiegrebe, Dieter Gurster, Susanne Peters, nee Piwek
  • 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals
    Patent number: 5661187
    Abstract: Therapeutic compositions comprising 1,8-dihyroxy-9(10H) anthracenones substituted at position 10 thereof with phenylalkylidene or arylacyl blocking moieties, said compounds having substantial therapeutic activity and minimal inflammatory effect.
    Type: Grant
    Filed: March 7, 1995
    Date of Patent: August 26, 1997
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Klaus Muller, Wolfgang Wiegrebe, Dieter Gurster, Susanne Peters, nee Piwek
  • 10-substituted 1,8-dihydroxy-9(10H) anthracenone pharmaceuticals
    Patent number: 5426197
    Abstract: Therapeutic compositions comprising 1,8-dihyroxy-9(10H) anthracenones substituted at position 10 thereof with phenylalkylidene or arylacyl blocking moieties, said compounds having substantial therapeutic activity and minimal inflammatory effect.
    Type: Grant
    Filed: July 19, 1993
    Date of Patent: June 20, 1995
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Klaus Muller, Wolfgang Wiegrebe, Dieter Gurster, Susanne Peters, nee Piwek